Informationen zur Anzeige:
PhD Student in Cancer Evolution
München
Aktualität: 08.03.2023
Anzeigeninhalt:
08.03.2023, Deutsches Krebsforschungszentrum (DKFZ)
München
PhD Student in Cancer Evolution
The Department of Medicine III (University Hospital of Munich, LMU, Spiekermann lab) and the Core Facility "Mouse Models of Acute Leukemias" (Helmholtz Munich / Jeremias lab) at the DKTK partner site Munich are offering a PhD position as part of the programs »Molecular Diagnostics, Early Detection and Biomarker Development« and »Exploitation of Oncogenic Mechanisms«.
Therapy resistance is a major problem in cancer therapy resulting in cancer recurrence and finally therapy failure. This translational project focusses on acquired mechanisms of resistance towards targeted agents in acute leukemias with a focus on Antibody Drug Conjugates (ADC). Multi-omics characterization of in vitro and in vivo models of drug resistance will be used to identify candidates for functional characterization. Moreover, clinical samples will be characterized to validate findings from model systems in human disease.
The project will require approximately 50% wet lab und 50% dry lab work.
Above-average master's or diploma degree in medical or life sciences (biology or a related discipline)
Experience with techniques of molecular biology and interests in cell culture, protein analysis and molecular biology (mutagenesis, cloning, expression, gene knockouts with CRISPR / Cas)
Interest in bioinformatics and experience with R (programming / statistics)
Excellent communication skills in English, spoken and written
Eagerness to learn and contribute to future cancer characterization, in particular working with genome-wide expression, mutation and DNA methylation data
Enjoy working in a dynamic, interdisciplinary environment (lab medicine, clinics)
Strong motivation, scientific curiosity and commitment to scientific excellence
Berufsfeld
Bundesland
Standorte